Locus Cell Co., Ltd. (TPEX:6891)

Locus Cell Statistics

Total Valuation

Locus Cell has a market cap or net worth of TWD 5.84 billion. The enterprise value is 5.09 billion.

Market Cap	5.84B
Enterprise Value	5.09B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Locus Cell has 200.00 million shares outstanding.

Current Share Class	200.00M
Shares Outstanding	200.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.74%
Owned by Institutions (%)	n/a
Float	72.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,128.28
PB Ratio	3.59
P/TBV Ratio	3.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.99
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.97

Financial Position

The company has a current ratio of 22.57, with a Debt / Equity ratio of 0.05.

Current Ratio	22.57
Quick Ratio	21.15
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.13
Interest Coverage	-143.06

Financial Efficiency

Return on equity (ROE) is -9.65% and return on invested capital (ROIC) is -5.93%.

Return on Equity (ROE)	-9.65%
Return on Assets (ROA)	-5.77%
Return on Invested Capital (ROIC)	-5.93%
Return on Capital Employed (ROCE)	-10.01%
Revenue Per Employee	97,660
Profits Per Employee	-3.10M
Employee Count	53
Asset Turnover	0.00
Inventory Turnover	0.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.11% in the last 52 weeks. The beta is 0.63, so Locus Cell's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+13.11%
50-Day Moving Average	32.02
200-Day Moving Average	24.40
Relative Strength Index (RSI)	35.59
Average Volume (20 Days)	239,386

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Locus Cell had revenue of TWD 5.18 million and -164.24 million in losses. Loss per share was -0.83.

Revenue	5.18M
Gross Profit	3.62M
Operating Income	-168.38M
Pretax Income	-164.24M
Net Income	-164.24M
EBITDA	-155.11M
EBIT	-168.38M
Loss Per Share	-0.83

Balance Sheet

The company has 825.01 million in cash and 74.98 million in debt, giving a net cash position of 750.02 million or 3.75 per share.

Cash & Cash Equivalents	825.01M
Total Debt	74.98M
Net Cash	750.02M
Net Cash Per Share	3.75
Equity (Book Value)	1.62B
Book Value Per Share	8.12
Working Capital	846.53M

Cash Flow

In the last 12 months, operating cash flow was -143.83 million and capital expenditures -423.37 million, giving a free cash flow of -567.20 million.

Operating Cash Flow	-143.83M
Capital Expenditures	-423.37M
Free Cash Flow	-567.20M
FCF Per Share	-2.84

Margins

Gross Margin	69.86%
Operating Margin	-3,253.09%
Pretax Margin	-3,173.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Locus Cell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.81%
FCF Yield	-9.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Locus Cell has an Altman Z-Score of 29.35 and a Piotroski F-Score of 4.

Altman Z-Score	29.35
Piotroski F-Score	4